Inhibition by neuroprotective drug NS-7 of nicotine-induced 22Na+ influx, 45Ca2+ influx and catecholamine secretion in adrenal chromaffin cells

Brain Research

Volumn 873, Issue 1, 2000, Pages 149-154

  Yokoo, Hiroki ^a   Shiraishi, Seiji ^a   Kobayashi, Hideyuki ^a   Yanagita, Toshihiko ^a   Minami, Shin ichi ^a   Yamamoto, Ryuichi ^a   Wada, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

22Na+ influx; 45Ca2+ influx; Adrenal chromaffin cell; Catecholamine secretion; Neuroprotective drug; Nicotinic receptor

Indexed keywords

4 (4 FLUOROPHENYL) 2 METHYL 6 (5 PIPERIDINOPENTYLOXY)PYRIMIDINE; NEUROPROTECTIVE AGENT; NICOTINE; OUABAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CATECHOLAMINE EXCRETION; CATTLE; CELL CULTURE; CHROMAFFIN CELL; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; ISOTOPE LABELING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SODIUM TRANSPORT;

ADRENAL GLANDS; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM RADIOISOTOPES; CATECHOLAMINES; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; ENZYME INHIBITORS; NA(+)-K(+)-EXCHANGING ATPASE; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC AGONISTS; OUABAIN; PYRIMIDINES; RECEPTORS, NICOTINIC; SODIUM; SODIUM RADIOISOTOPES;

EID: 0034604787     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02492-6     Document Type: Article

References (41)

1. Akaike A., Tamura Y., Yokota T., Shimohama S., Kimura J. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644:1994;181-187.
2. Baker A.J., Zornow M.H., Scheller M.S., Yaksh T.L., Skilling S.R., Smullin D.H., Larson A.A., Kuczenski R. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57:1991;1370-1379.
3. Berger F., Gage F.H., Vijayaraghavan S. Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells. J. Neurosci. 18:1998;6871-6881.
4. Borlongan C.V., Shytle R.D., Ross S.D., Shimizu T., Freeman T.B., Cahill D.W., Sanberg P.R. (-)-Nicotine protects against systemic kainic acid-induced excitotoxic effects. Exp. Neurol. 136:1995;261-265.
5. Buisson A., Callebert J., Mathieu E., Plotkine M., Boulu R.G. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J. Neurochem. 59:1992;1153-1157.
6. Busto R., Harik S.I., Yoshida S., Scheinberg P., Ginsberg M.D. Cerebral norepinephrine depletion enhances recovery after brain ischemia. Ann. Neurol. 18:1985;329-336.
7. Campos-Caro A., Smillie F.I., Domínguez del Toro E., Rovira J.C., Vicente-Agulló F., Chapuli J., Juíz J.M., Sala S., Sala F., Ballesta J.J., Criado M. Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits. J. Neurochem. 68:1997;488-497.
8. 7 subunit. Eur. J. Neurosci. 7:1995;647-655.
9. Globus M.Y.-T., Busto R., Dietrich W.D., Martinez E., Valdés I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1988;1455-1464.
10. Globus M.Y.-T., Busto R., Dietrich W.D., Martinez E., Valdés I., Ginsberg M.D. Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J. Cereb. Blood Flow Metab. 9:1989;892-896.
11. Hadjiconstantinou M., Hubble J.P., Wemlinger T.A., Neff N.H. Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists. J. Pharmacol. Exp. Ther. 270:1994;639-644.
12. Hory-Lee F., Frank E. The nicotinic blocking agents d-tubocurare and α-bungarotoxin save motoneurons from naturally occurring cell death in the absence of neuromuscular blockade. J. Neurosci. 15:1995;6453-6460.
13. Itoh Y., Aoki Y., Nonaka K., Ukai Y., Yoshikuni Y., Kimura K. Permeability of a neuroprotective compound NS-7 into brain: comparison between normal and middle cerebral artery-occluded rats. Life Sci. 61:1997;957-966.
14. ++ channel blocker NS-7 inhibits evoked but not spontaneous dopamine release from rat striatum, as measured by intracerebral microdialysis. Neurosci. Lett. 252:1998;203-206.
15. Janson A.M., Fuxe K., Goldstein M. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse. Clin. Invest. 70:1992;232-238.
16. 7-neuronal receptors and neuronal CNS receptors. Brain Res. 765:1997;135-140.
17. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T., Akaike A. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42:1997;159-163.
18. 2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity. Brain Res. 792:1998;331-334.
19. Léna C., Changeux J.P. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci. 16:1993;181-186.
20. 7 nicotinic receptor activation in PC12 cells. Brain Res. 830:1999;218-225.
21. 7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc. Natl. Acad. Sci. USA. 95:1998;14184-14189.
22. Marin P., Maus M., Desagher S., Glowinski J., Premont J. Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport. 5:1994;1977-1980.
23. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
24. Miñana M.-D., Montoliu C., Llansola M., Grisolía S., Felipo V. Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons. Neuropharmacology. 37:1998;847-857.
25. Mollard P., Seward E.P., Nowycky M.C. Activation of nicotinic receptors triggers exocytosis from bovine chromaffin cells in the absence of membrane depolarization. Proc. Natl. Acad. Sci. USA. 92:1995;3065-3069.
26. ++ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture. J. Neurochem. 72:1999;1315-1322.
27. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
28. Shimidzu T., Itoh Y., Tatsumi S., Hayashi S., Ukai Y., Yoshikuni Y., Kimura K. Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;601-608.
29. 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. Brain Res. 779:1998;359-363.
30. ++ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cells. Eur. J. Pharmacol. 336:1997;283-290.
31. Takagaki Y., Itoh Y., Aoki Y., Ukai Y., Yoshikuni Y., Kimura K. Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: an implication for its neuroprotective action in rats with middle cerebral artery occlusion. J. Neurochem. 68:1997;2507-2513.
32. ++ channel blocker, NS-7, suppresses hypoxic injury in rat cerebrocortical slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;191-196.
33. Tatsumi S., Itoh Y., Ma F.-H., Higashira H., Ukai Y., Yoshikuni Y., Kimura K. Inhibition of depolarization-induced nitric oxide synthase activation by NS-7, a phenylpyrimidine derivative, in primary neuronal culture. J. Neurochem. 70:1998;59-65.
34. Toner C.C., Stamford J.A. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro. Neuroscience. 81:1997;999-1007.
35. + channels: a rational and effective strategy against ischemic brain damage. Pharmacol. Rev. 48:1996;21-67.
36. Vernino S., Rogers M., Radcliffe K.A., Dani J.A. Quantitative measurement of calcium flux through muscle and neuronal nicotinic acetylcholine receptors. J. Neurosci. 14:1994;5514-5524.
37. ++ influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience. 15:1985;283-292.
38. + in cultured bovine adrenal medullary cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;351-356.
39. Weinberger J., Nieves-Rosa J., Cohen G. Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-para-tyrosine. Stroke. 16:1985;864-870.
40. Yamamoto R., Yanagita T., Kobayashi H., Yokoo H., Wada A. Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells. J. Neurochem. 68:1997;1655-1662.
41. Zhou Z., Neher E. Calcium permeability of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells. Pflügers Arch. 425:1993;511-517.